AVMA Welcomes Passage of Animal Drug User Fee Legislation

AVMA sees the act as vital for increasing veterinary access to drugs approved by the U.S. Food and Drug Administration (FDA).
AVMA sees the act as vital for increasing veterinary access to drugs approved by the U.S. Food and Drug Administration (FDA).
(John Maday)

​The American Veterinary Medical Association (AVMA) applauds House and Senate lawmakers for their passage of the Animal Drug and Animal Generic Drug User Fee Amendments of 2018 (H.R. 5554/S.2434), which are vital to increasing veterinary access to drugs approved by the U.S. Food and Drug Administration (FDA). The House passed the bill on July 16, and the Senate passed the bill today. In a significant victory for the veterinary community, the legislation includes language that would expand conditional approvals beyond minor uses and minor species.

When signed into law, the animal drug user fee amendments will reauthorize the FDA's Center for Veterinary Medicine to continue collecting animal drug and animal generic drug user fees from the drugs' sponsors. These fees – coupled with annual appropriations – support FDA's animal drug review processes and ultimately improve veterinary access to FDA-approved drugs. Conditional approval of new animal drugs will incentivize the development of new and innovative products for conditions that prove particularly difficult to study.

AVMA has been a vocal proponent of timely passage of animal drug user fee amendments and expansion of conditional approvals. On March 14, AVMA Immediate Past-President Dr. Michael Topper testified before the U.S. House of Representatives Committee on Energy and Commerce Subcommittee on Health in favor of the legislation.

"By providing new animal drugs with a predictable pathway to market, these fees help provide veterinarians with access to new and additional tools that can potentially improve treatment outcomes, provide alternatives to existing therapies, fill unmet medical needs in veterinary medicine, and ultimately improve patient care, which is the center of veterinary practice," Dr. Topper told members of the committee.

This legislation is critical to veterinary access to more FDA-approved medications, as there are roughly 25 times more labeled indications approved for human use than approved for animal use.

 

Latest News

Endovac Names New National Sales Director
Endovac Names New National Sales Director

Darren Schmadeke is leading the Endovac sales team as it builds new opportunities for the company's products.

Liver Abscesses in Beef-on-Dairy Cattle are Costing Packers Big Money
Liver Abscesses in Beef-on-Dairy Cattle are Costing Packers Big Money

This growing beef-on-dairy health problem is costing packers two major things – time and money.

  New Dean Selected for UT College of Veterinary Medicine
New Dean Selected for UT College of Veterinary Medicine

Dr. Paul J. Plummer, DVM and PhD, a native of Sevierville, Tenn., has been named the next dean for the University of Tennessee College of Veterinary Medicine.  

Estrus Detection Aids and Timed Cattle Breeding
Estrus Detection Aids and Timed Cattle Breeding

The advent of timed AI protocols became a game-changer in allowing professionals, like AI technicians or veterinarians, to breed many females effectively and quickly.

Meat Institute Honors 2023 Environmental Achievement Award Winners
Meat Institute Honors 2023 Environmental Achievement Award Winners

More than 200 meat and poultry plants were recognized by The Meat Institute at the 2024 Environmental, Labor and Safety+ Conference in New Orleans for their positive environmental impact efforts.

NIAA Recognizes Industry Leaders and Elects Directors
NIAA Recognizes Industry Leaders and Elects Directors

More than 120 guests attended the National Institute for Animal Agriculture conference to discuss gaps in animal agriculture technology and innovation and identify solutions to improve today’s food system.